Skip to content

lifestyle.capitolhilltimes.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • RGP Appoints Jessica Block as Chief Artificial Intelligence Officer to Accelerate AI at the Core of Its Business and Client Offerings

    RGP Appoints Jessica Block as Chief Artificial Intelligence Officer to Accelerate AI at the Core of Its Business and Client Offerings

    Business Wire
    April 7, 2026
  • Nodal Exchange Sets New Trading Volume Records in Q1 2026

    Nodal Exchange Sets New Trading Volume Records in Q1 2026

    Business Wire
    April 7, 2026
  • Identy.io to Join Global Border Officials at the World Border Security Congress, April 14-16, 2026.

    Identy.io to Join Global Border Officials at the World Border Security Congress, April 14-16, 2026.

    Business Wire
    April 7, 2026
  • Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe

    Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe

    Business Wire
    April 7, 2026
  • IKS Health Announces Launch of Audit-Ready Autonomous Coding Capabilities

    IKS Health Announces Launch of Audit-Ready Autonomous Coding Capabilities

    Business Wire
    April 7, 2026
  • Peruvian Army Selects Beechcraft King Air 360C for Multi-Mission Operation

    Peruvian Army Selects Beechcraft King Air 360C for Multi-Mission Operation

    Business Wire
    April 7, 2026
  • Avolon Q1 2026 Business Update

    Avolon Q1 2026 Business Update

    Business Wire
    April 7, 2026
  • Counsel Health Expands Clinical Care, Launching Chronic Condition Services

    Counsel Health Expands Clinical Care, Launching Chronic Condition Services

    Business Wire
    April 7, 2026
  • Planet Successfully Runs AI in Space

    Planet Successfully Runs AI in Space

    Business Wire
    April 7, 2026
  • Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026

    Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026

    Business Wire
    April 7, 2026
Prev
1 … 12,493 12,494 12,495 12,496 12,497 … 38,690
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.